Sales increase 22 percent from the previous year to $290 million in the fourth quarter and 27 percent to $1 billion for the year
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that – in accordance with applicable IFRS accounting standards – the remaining impairment of approximately 55 million for DSM Anti-Infectives will be reversed in Q4 2010. This reversal of impairment will be reported as an exceptional item in DSM’s Q4 2010 results, which will be published on 23 February 2011.
With immediate effect, BASF is increasing the sales prices for higher alkylamines in Europe as follows:
BASF-YPC celebrates 10-year anniversary with new expansion plans
Fraser Papers Inc. (together with its subsidiaries, “Fraser Papers” or the “Company”) announced today that it completed the sale of its paper mill in Gorham, New Hampshire on December 16, 2010, to a subsidiary of Counsel RB Capital, LLC.
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will increase list and off-list selling prices for the following products by the amounts indicated effective January 1, 2011, or as contracts allow.
Eastman Chemical Company is increasing prices on the following products effective Jan. 1, or as contracts allow. These increases are due to elevated operating costs, particularly in raw materials
